By Chris Wack MeiraGTx Holdings shares were up 20% to $5.89 after the company entered into an asset purchase agreement with Janssen Pharmaceuticals for the.
- MeiraGTx enters into an Asset Purchase Agreement related to botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked retinitis pigmentosa (XLRP) for a total of up to $415
Form 8-K MeiraGTx Holdings plc For: Dec 20 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MeiraGTx Holdings plc (MGTX) shares are gaining more than 22 percent on Thursday morning trade after the company announced an asset purchase agreement with Johnson & Johnson's Janssen Pharmaceuticals, Inc.
MeiraGTx Holdings shares rose 22% in recent Thursday trading after the company agreed to sell the remaining interests in botaretigene sparoparvovec or bota-vec, to Johnson & Johnson s Janssen.